P43-38870-26248
3 vaccinations
7 coded responses
36 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 553 / MN
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Moderna
- 2021-03-11
- 2021-03-12
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Moderna
- 2021-04-08
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
-
2021-05-20
Survey response — day 42, dose 2MedDRA: Dermatitis contact, Rash — Feeling: GoodFree text: Rash on knee (probably poison ivy not vaccine-related)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-11
- 2021-10-07
-
2021-11-20
Dose 3 — Moderna
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-12-04
-
2021-12-11
Survey response — day 21, dose 3MedDRA: Viral infection — Feeling: FairFree text: virus unrelated to vaccineMedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Survey response — day 42, dose 3MedDRA: Cough, Malaise, Nasopharyngitis, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cold, cough, congestion, low-grade fever, general malaiseMedDRA releases: 2024-11 · check-in free text available
-
2022-02-21
Survey response — 3 months, dose 3MedDRA: COVID-19, Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Sinus infection after Covid-19 infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-21
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-25
Call successfulNot applicable - Accidental Reporting
-
2022-05-21
Survey response — 6 months, dose 3MedDRA: Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Various viral/cold/allergies going aroundMedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-23
- 2022-05-23
-
2022-11-22
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: FairFree text: Pregnancy-related symptoms/effectsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Moderna | |
| 2 | 2021-04-08 | Moderna | |
| 3 | 2021-11-20 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): No
Release 8 — day 42, dose 2
Symptoms: Rash on knee (probably poison ivy not vaccine-related)
Release 10 — day 21, dose 3
Symptoms: virus unrelated to vaccine
Release 10 — day 42, dose 3
Symptoms: Cold, cough, congestion, low-grade fever, general malaise
Release 11 — 3 months, dose 3
Symptoms: Sinus infection after Covid-19 infection
Release 11 — 6 months, dose 3
Symptoms: Various viral/cold/allergies going around
Release 12 — 12 months, dose 3
Symptoms: Pregnancy-related symptoms/effects
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dermatitis contact | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release